Co-transplantation of syngeneic mesenchymal stem cells improves survival of allogeneic glial-restricted precursors in mouse brain

Amit K. Srivastava, Camille A. Bulte, Irina Shats, Piotr Walczak, Jeff W Bulte

Research output: Contribution to journalArticle

Abstract

Loss of functional cells from immunorejection during the early post-transplantation period is an important factor that reduces the efficacy of stem cell-based therapies. Recent studies have shown that transplanted mesenchymal stem cells (MSCs) can exert therapeutic effects by secreting anti-inflammatory and pro-survival trophic factors. We investigated whether co-transplantation of MSCs could improve the survival of other transplanted therapeutic cells. Allogeneic glial-restricted precursors (GRPs) were isolated from the brain of a firefly luciferase transgenic FVB mouse (at E13.5 stage) and intracerebrally transplanted, either alone, or together with syngeneic MSCs in immunocompetent BALB/c mice (n=20) or immunodeficient Rag2-/- mice as survival control (n=8). No immunosuppressive drug was given to any animal. Using bioluminescence imaging (BLI) as a non-invasive readout of cell survival, we found that co-transplantation of MSCs significantly improved (p-/- mice, with transplanted cells surviving in both the GRP only and the GRP+MSC group. In contrast, on day 21 post-transplantation, we observed a 94.2% decrease in BLI signal intensity in immunocompetent mice transplanted with GRPs alone versus 68.1% in immunocompetent mice co-transplanted with MSCs and GRPs (p+ and CD8+ cells, reduced astrogliosis, and a higher number of FoxP3+ cells at the site of transplantation for the immunocompetent mice receiving MSCs. The present study demonstrates that co-transplantation of MSCs can be used to create a microenvironment that is more conducive to the survival of allogeneic GRPs.

Original languageEnglish (US)
Pages (from-to)154-161
Number of pages8
JournalExperimental Neurology
Volume275
DOIs
StatePublished - Jan 1 2016

Fingerprint

Isogeneic Transplantation
Neuroglia
Cell Survival
Mesenchymal Stromal Cells
Mesenchymal Stem Cell Transplantation
Brain
Transplantation
Firefly Luciferases
Therapeutic Uses
Immunosuppressive Agents
Cell- and Tissue-Based Therapy
Transgenic Mice
Anti-Inflammatory Agents
Stem Cells
Cell Count
Pharmaceutical Preparations

Keywords

  • Bioluminescence imaging
  • Cell survival
  • Co-transplantation
  • Glial-restricted precursor
  • Immunomodulation
  • Mesenchymal stem cell

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Co-transplantation of syngeneic mesenchymal stem cells improves survival of allogeneic glial-restricted precursors in mouse brain. / Srivastava, Amit K.; Bulte, Camille A.; Shats, Irina; Walczak, Piotr; Bulte, Jeff W.

In: Experimental Neurology, Vol. 275, 01.01.2016, p. 154-161.

Research output: Contribution to journalArticle

@article{e132fdd8cbf049d5a6fd0986aac4808c,
title = "Co-transplantation of syngeneic mesenchymal stem cells improves survival of allogeneic glial-restricted precursors in mouse brain",
abstract = "Loss of functional cells from immunorejection during the early post-transplantation period is an important factor that reduces the efficacy of stem cell-based therapies. Recent studies have shown that transplanted mesenchymal stem cells (MSCs) can exert therapeutic effects by secreting anti-inflammatory and pro-survival trophic factors. We investigated whether co-transplantation of MSCs could improve the survival of other transplanted therapeutic cells. Allogeneic glial-restricted precursors (GRPs) were isolated from the brain of a firefly luciferase transgenic FVB mouse (at E13.5 stage) and intracerebrally transplanted, either alone, or together with syngeneic MSCs in immunocompetent BALB/c mice (n=20) or immunodeficient Rag2-/- mice as survival control (n=8). No immunosuppressive drug was given to any animal. Using bioluminescence imaging (BLI) as a non-invasive readout of cell survival, we found that co-transplantation of MSCs significantly improved (p-/- mice, with transplanted cells surviving in both the GRP only and the GRP+MSC group. In contrast, on day 21 post-transplantation, we observed a 94.2{\%} decrease in BLI signal intensity in immunocompetent mice transplanted with GRPs alone versus 68.1{\%} in immunocompetent mice co-transplanted with MSCs and GRPs (p+ and CD8+ cells, reduced astrogliosis, and a higher number of FoxP3+ cells at the site of transplantation for the immunocompetent mice receiving MSCs. The present study demonstrates that co-transplantation of MSCs can be used to create a microenvironment that is more conducive to the survival of allogeneic GRPs.",
keywords = "Bioluminescence imaging, Cell survival, Co-transplantation, Glial-restricted precursor, Immunomodulation, Mesenchymal stem cell",
author = "Srivastava, {Amit K.} and Bulte, {Camille A.} and Irina Shats and Piotr Walczak and Bulte, {Jeff W}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.expneurol.2015.10.008",
language = "English (US)",
volume = "275",
pages = "154--161",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Co-transplantation of syngeneic mesenchymal stem cells improves survival of allogeneic glial-restricted precursors in mouse brain

AU - Srivastava, Amit K.

AU - Bulte, Camille A.

AU - Shats, Irina

AU - Walczak, Piotr

AU - Bulte, Jeff W

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Loss of functional cells from immunorejection during the early post-transplantation period is an important factor that reduces the efficacy of stem cell-based therapies. Recent studies have shown that transplanted mesenchymal stem cells (MSCs) can exert therapeutic effects by secreting anti-inflammatory and pro-survival trophic factors. We investigated whether co-transplantation of MSCs could improve the survival of other transplanted therapeutic cells. Allogeneic glial-restricted precursors (GRPs) were isolated from the brain of a firefly luciferase transgenic FVB mouse (at E13.5 stage) and intracerebrally transplanted, either alone, or together with syngeneic MSCs in immunocompetent BALB/c mice (n=20) or immunodeficient Rag2-/- mice as survival control (n=8). No immunosuppressive drug was given to any animal. Using bioluminescence imaging (BLI) as a non-invasive readout of cell survival, we found that co-transplantation of MSCs significantly improved (p-/- mice, with transplanted cells surviving in both the GRP only and the GRP+MSC group. In contrast, on day 21 post-transplantation, we observed a 94.2% decrease in BLI signal intensity in immunocompetent mice transplanted with GRPs alone versus 68.1% in immunocompetent mice co-transplanted with MSCs and GRPs (p+ and CD8+ cells, reduced astrogliosis, and a higher number of FoxP3+ cells at the site of transplantation for the immunocompetent mice receiving MSCs. The present study demonstrates that co-transplantation of MSCs can be used to create a microenvironment that is more conducive to the survival of allogeneic GRPs.

AB - Loss of functional cells from immunorejection during the early post-transplantation period is an important factor that reduces the efficacy of stem cell-based therapies. Recent studies have shown that transplanted mesenchymal stem cells (MSCs) can exert therapeutic effects by secreting anti-inflammatory and pro-survival trophic factors. We investigated whether co-transplantation of MSCs could improve the survival of other transplanted therapeutic cells. Allogeneic glial-restricted precursors (GRPs) were isolated from the brain of a firefly luciferase transgenic FVB mouse (at E13.5 stage) and intracerebrally transplanted, either alone, or together with syngeneic MSCs in immunocompetent BALB/c mice (n=20) or immunodeficient Rag2-/- mice as survival control (n=8). No immunosuppressive drug was given to any animal. Using bioluminescence imaging (BLI) as a non-invasive readout of cell survival, we found that co-transplantation of MSCs significantly improved (p-/- mice, with transplanted cells surviving in both the GRP only and the GRP+MSC group. In contrast, on day 21 post-transplantation, we observed a 94.2% decrease in BLI signal intensity in immunocompetent mice transplanted with GRPs alone versus 68.1% in immunocompetent mice co-transplanted with MSCs and GRPs (p+ and CD8+ cells, reduced astrogliosis, and a higher number of FoxP3+ cells at the site of transplantation for the immunocompetent mice receiving MSCs. The present study demonstrates that co-transplantation of MSCs can be used to create a microenvironment that is more conducive to the survival of allogeneic GRPs.

KW - Bioluminescence imaging

KW - Cell survival

KW - Co-transplantation

KW - Glial-restricted precursor

KW - Immunomodulation

KW - Mesenchymal stem cell

UR - http://www.scopus.com/inward/record.url?scp=84946780859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946780859&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2015.10.008

DO - 10.1016/j.expneurol.2015.10.008

M3 - Article

C2 - 26515691

AN - SCOPUS:84946780859

VL - 275

SP - 154

EP - 161

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

ER -